Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Lancet Diabetes Endocrinol. 2017 May;5(5):367-376. doi: 10.1016/S2213-8587(17)30064-5. Epub 2017 Mar 2.
25-hydroxyvitamin D (25[OH]D) concentrations during fetal life might have long-lasting effects on skeletal development, but results from previous studies are inconsistent. We investigated the associations of maternal and fetal 25(OH)D concentrations with childhood bone health.
In a prospective multiethnic population-based cohort study, embedded within the Generation R Study (Rotterdam, Netherlands), pregnant women living in the study area with an expected delivery date between April 1, 2002, and Jan 1, 2006, were eligible for participation in the study at our research centre in the Erasmus MC-Sophia Children's Hospital. We measured maternal 25(OH)D concentrations during mid-pregnancy (at a median of 20·4 weeks gestation [IQR 19·9-21·1]) and fetal 25(OH)D concentrations at birth (at a median of 40·1 weeks gestation [39·3-41·0]). We measured total-body bone mineral density, bone mineral content (BMC), area-adjusted BMC, and bone area using dual-energy X-ray absorptiometry (DXA) in offspring at 6 years of age. We examined associations using multivariable linear regression models, adjusted for several sociodemographic and lifestyle variables, and for child's height.
We enrolled 9901 mother-and-child pairs and obtained both mid-pregnancy maternal 25(OH)D concentrations and offspring DXA scans at age 6 years in 4815 pairs. Severe maternal 25(OH)D deficiency (<25 nmol/L) during mid-pregnancy was associated with higher offspring BMC (4·71 g, 95% CI 1·09 to 8·33; p=0·011) and larger bone area (7·54 cm, 2·99 to 12·11; p=0·001) at age 6 years, compared with maternal 25(OH)D sufficiency (≥50 nmol/L) during mid-pregnancy. However, in a subgroup of children with available data on 25(OH)D concentrations at 6 years (n=3034), such associations for BMC (4·67 g, -0·05 to 9·39; p=0·052) and bone area (5·25 cm, -0·41 to 10·91; p=0·069) were no longer significant after adjustment for the child's own 25(OH)D concentrations. No associations were seen between maternal 25(OH)D concentrations in mid-pregnancy and offspring bone mineral density (1·07 mg/cm, -1·84 to 3·99; p=0·47) or area-adjusted BMC (-1·58 g, -4·72 to 1·61; p=0·32), and the association with skeletal parameters at 6 years did not differ by maternal BMI, maternal calcium intake, child sex, or weight status. Similar associations were seen with fetal 25(OH)D concentrations at birth.
We found inverse associations between 25(OH)D concentrations during fetal life with BMC and bone area in childhood, but these associations were no longer significant after adjustment for childhood 25(OH)D status. Our data suggest that 25(OH)D concentrations during childhood might be more relevant for bone outcomes than than 25(OH)D concentrations during fetal life.
Erasmus University Medical Center, Organization for Health Research and Development (ZonMw), Organization for Scientific Research (NWO), the Ministry of Health, Welfare and Sport.
胎儿期的 25-羟维生素 D(25[OH]D)浓度可能对骨骼发育有持久影响,但先前的研究结果并不一致。我们研究了母代和胎儿 25(OH)D 浓度与儿童期骨骼健康的关联。
在一项前瞻性多民族人群队列研究中,该研究嵌入在 Rotterdam 的 Generation R 研究中(荷兰),在研究区域内居住并预计在 2002 年 4 月 1 日至 2006 年 1 月 1 日期间分娩的孕妇有资格在我们在 Erasmus MC-Sophia 儿童医院的研究中心参加该研究。我们在妊娠中期(中位数 20.4 周妊娠[IQR 19.9-21.1])测量了母体 25(OH)D 浓度,在出生时(中位数 40.1 周妊娠[39.3-41.0])测量了胎儿 25(OH)D 浓度。我们使用双能 X 射线吸收法(DXA)在 6 岁时测量了后代的全身骨矿物质密度、骨矿物质含量(BMC)、面积校正的 BMC 和骨面积。我们使用多变量线性回归模型进行了检查,模型调整了几个社会人口统计学和生活方式变量以及孩子的身高。
我们纳入了 9901 对母婴对,并在 4815 对中获得了妊娠中期母体 25(OH)D 浓度和后代 DXA 扫描。与妊娠中期母体 25(OH)D 充足(≥50 nmol/L)相比,妊娠中期母体 25(OH)D 严重缺乏症(<25 nmol/L)与儿童 6 岁时的 BMC(4.71 g,95%CI 1.09 至 8.33;p=0.011)和更大的骨面积(7.54 cm,2.99 至 12.11;p=0.001)相关。然而,在具有 6 岁时 25(OH)D 浓度可用数据的儿童子组(n=3034)中,这种对 BMC(4.67 g,-0.05 至 9.39;p=0.052)和骨面积(5.25 cm,-0.41 至 10.91;p=0.069)的关联在调整了孩子自身 25(OH)D 浓度后不再显著。母体妊娠中期 25(OH)D 浓度与后代骨矿物质密度(1.07 mg/cm,-1.84 至 3.99;p=0.47)或面积校正的 BMC(-1.58 g,-4.72 至 1.61;p=0.32)之间没有关联,与 6 岁时骨骼参数的关联也不因母体 BMI、母体钙摄入量、儿童性别或体重状态而异。在出生时胎儿 25(OH)D 浓度也存在类似的关联。
我们发现胎儿期的 25(OH)D 浓度与儿童期的 BMC 和骨面积之间存在负相关,但在调整了儿童期 25(OH)D 状态后,这些关联不再显著。我们的数据表明,25(OH)D 浓度在儿童期可能比胎儿期更能反映骨骼发育结果。
伊拉斯谟大学医学中心、健康研究与发展组织(ZonMw)、科学研究组织(NWO)、卫生部、福利和体育部。